Evidence map›Paper›PMID 40285687›Full record

ArticleCurrent protocols2025

Purification of Low-Complexity Domain Proteins FUS, EWSR1, and Their Fusions.

Jesse J Altemus, Michelle A Lay, Valery F Thompson, Jacob C Schwartz

Abstract read
In one paragraph

Article in Current protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jesse J AltemusDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, Arizona.
Michelle A LayUniversity of Arizona Cancer Center, Tucson, Arizona.
Valery F ThompsonDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, Arizona.
Jacob C SchwartzDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, Arizona.ORCID https://orcid.org/0000-0002-5205-564X

Funding

Phase separation control of transcription in Ewing sarcomaR01CA259570 · NCI · UNIVERSITY OF ARIZONA · PI Jacob C. Schwartz · 2022 to 2026
$1.7M
NCI NIH HHS R01 CA259570
6 · The paper itself

Abstract

FET proteins are large multifunctional proteins that have several key roles in biology. The FET family of proteins, including FUS, EWSR1, and TAF15, play critical roles in transcription regulation, RNA processing, and DNA damage repair. These multifunctional RNA- and DNA-binding proteins are ubiquitously expressed and conserved across vertebrate species. They contain low-complexity (LC) domains that allow them to assemble and phase separate but also makes the proteins prone to aggregation. Aberrations in FET proteins, such as point mutations, aggregation, or translocations leading to fusion proteins, have been implicated in several pathologies, including frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS), and Ewing sarcoma. In vitro study of FET proteins is hampered by their propensity to aggregate, their disordered structure, and their susceptibility to proteolysis, making high-yield production difficult. Here, we present optimized methods for the purification of full-length FUS, EWSR1, and their fusion proteins. These protocols enable researchers to overcome issues related to aggregation and solubility, facilitating biochemical and biophysical studies of these critical yet complex proteins. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol: Purification of EWSR1 and FUS proteins Alternate Protocol: Purification for fusion proteins.

Indexed as

Oncogene Proteins, FusionRNA-Binding Protein EWSRNA-Binding Protein FUSHumansProtein DomainsEWSR1 protein, humanFUS protein, humanOncogene Proteins, FusionRNA-Binding Protein EWSRNA-Binding Protein FUSEwing sarcomafusion proteinlow‐complexity domainneurodegenerative diseasephase separationprotein purification

Identifiers

PMID40285687
PMCPMC12032855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.